Skip to content
Government Federal, Medical Health Aged Care

Heart Foundation welcomes passage of new e-cigarette legislation

Heart Foundation of Australia 2 mins read

Wednesday, 26 June, 2024

Heart Foundation welcomes passage of new e-cigarette legislation

New legislation passed by the Senate today will help protect young people from the harms of e-cigarettes and vapes

The Heart Foundation has welcomed the passage through the Senate of new legislation – The Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024 - that will help keep e-cigarettes and vapes out of the hands of children.

In recent years there has been a proliferation of illegal sales of e-cigarettes and vapes with the vaping industry trying to get a new generation hooked on nicotine, a drug that is known to increase the risk of a heart attack.

This legislation will help ensure that e-cigarettes and vapes will only be provided to adults through pharmacies, rather than illegal retailers that push vaping products with packaging and flavours designed to get children hooked on nicotine.

“E-cigarettes and vapes are not safe,” said David Lloyd, CEO of the Heart Foundation.

“The more we learn about 'vaping,' the more we understand its harmful effects on the human body, including its links to heart disease.

“One recent study found that any use of e-cigarettes is associated with a 33% increased risk of having a heart attack compared to people who have never used e-cigarettes.

“Add to that the high levels of nicotine that keep people addicted, and vaping is just another deadly and costly version of tobacco smoking, which already sadly costs our nation far too much in terms of pain and suffering, as well as billions of dollars in healthcare costs.

"We welcome the passage of this legislation and commend all members of parliament who supported it. Minister Butler's efforts in addressing this issue are as commendable as Nicola Roxon's work on plain packaging, showcasing a strong commitment to public health."

Media enquiries

Shaun Inguanzo, Media Manager, Heart Foundation
M: 0404 769 054 E: media@heartfoundation.org.au

About the Heart Foundation

The Heart Foundation is a not-for-profit organisation dedicated to fighting the single biggest killer of Australians – heart disease. For more than 60 years, it has led the battle to save lives and improve the heart health of all Australians. Its sights are set on a world where people don’t suffer or die prematurely because of heart disease.

Find out your risk of heart attack or stroke by using our Heart Age Calculator. To find out about the Heart Foundation’s research program or to make a donation, visit www.heartfoundation.org.au


Key Facts:

The Heart Foundation has welcomed the passage through the Senate of new vaping legislation.

The new legislation will help keep e-cigarettes and vapes out of the hands of children.

A recent study found that any use of e-cigarettes is associated with a 33% increased risk of having a heart attack compared to people who have never used e-cigarettes.


Contact details:

Shaun Inguanzo, Media Manager, Heart Foundation
M: 0404 769 054 E: media@heartfoundation.org.au

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.